Enliven Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Burlingame, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Enliven Therapeutics, Inc. has filed 783 SEC EDGAR filings since 21 Apr 2016

SEC filing history

Showing 101-125 of 783 matching filings.

Per page
25
Current page
5
4

4 filing

Filing date
19 Dec 2025
Reporting date
17 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
19 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
17 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Dec 2025
Reporting date
11 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
12 Dec 2025
Reporting date
11 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Dec 2025
Reporting date
08 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
08 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Nov 2025
Reporting date
19 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Nov 2025
Reporting date
17 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
19 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91465

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
12 Nov 2025
Reporting date
07 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-91465

SCHEDULE 13G/A filing

Filing date
05 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Oct 2025
Reporting date
20 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Oct 2025
Reporting date
17 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
20 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-39247

144 filing

Filing date
17 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
09 Oct 2025
Reporting date
07 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Oct 2025
Reporting date
29 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .